|
AVZO-021 Clinical Trials
2 actively recruiting trials across 2 locations
Los Angeles, California1 trial
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
Avenzo Therapeutics Recruiting Site
Phase 1/2
New Haven, Connecticut1 trial
Study of AVZO-021 in Patients With Advanced Solid Tumors
Yale Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.